References
- Dale I., Brandtzaeg P., Fagerhol M. K., Scott H. Distribution of a new myelomonocytic antigen (L1) in human peripheral blood leuckocytes. Am J Clin Pathol 1985; 84: 24–34
- Striz I., Trebichavsky I. Calprotectin – a pleiotropic molecule in acute and chronic inflammation. Physiol Res 2004; 53: 245–53
- Tibble J., Teahon K., Thjodleifsson B., Røseth A., Sigthorsson G., Bridger S., et al. A simple method for assessing intestinal inflammation in Crohn's disease. Gut 2000; 47: 506–13
- Fagerberg U. L., Lööf L., Myrdal U., Hansson L., Finkel Y. Colorectal inflammation is well predicted by fecal calprotectin in children with gastrointestinal symptoms. Pediatr Gastroenterol Nutr 2005; 40: 450–55
- Kronborg O., Ugstad M., Fuglerud P., Johne B., Hardcastle J., Scholefield J. H., et al. Fecal calprotectin levels in a high risk population for colorectal neoplasia. Gut 2000; 46: 795–800
- Røseth A. G., Fagerhol M. K., Aadland E., Schjønsby H. Assessment of the neutrophil dominating protein calprotectin in feces. Scand J Gastroenterol 1992; 27: 793–98
- Tøn H., Brandsnes Ø., Dale S., Holtlund J., Skuibina E., Schjønsby H., et al. Improved assay for fecal calprotectin. Clin Chim Acta 2000; 292: 41–54
- Tibble J. A., Sigthorsson G., Bridger S., Fagerhol M. K., Bjarnason I. Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology 2000; 119: 15–22
- Røseth A. G., Aadland E., Jahnsen J., Raknerud N. Assessment of disease activity in ulcerative colitis by fecal calprotectin, a novel granulocyte marker protein. Digestion 1997; 58: 176–80
- Bunn S. K., Bisset W. M., Main M. J. C., Gray E. S., Olson S., Golden B. E. Fecal calprotectin: validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease. Pediatr Gastroenterol Nutr 2001; 33: 14–22